"Organoids are set to become essential tools in medical research. The research program financed by SATT AxLR and the support of CTIBIOTECH, in this key stage, will enable Cilcare to accelerate the ...

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary, non-animal recombinant human collagen ...

PEMBROKE PARK, Fla. — October is Breast Cancer Awareness Month, and this year alone, more than 316,000 women in the U.S. are projected to be diagnosed with an invasive form of the disease, according ...

New York Tech and UC Irvine develop a 3D-printed human colon model to advance cancer drug testing and gastrointestinal ...

Researchers in Germany have created a groundbreaking 3D printer designed to print living tissue in the body through tiny ...

Swiss researchers recently have been developing 3D printed, biocompatible corneal implants that restore vision without donor ...

An update from Collplant Holdings ( ($CLGN) ) is now available. On October 16, 2025, CollPlant Biotechnologies announced the development of a ...

Regenerative medicine corporations T&R Biofab said on the 2nd that it has completed registration of a U.S. patent related to a “bio-ink supply system technology,” which is essential for mass-producing ...

Saudi Arabia's 3D printing medical devices market is driven by the growing demand for personalized implants and prosthetics, ...

Analysis by researchers at the University of Bern suggests that water and other volatile compounds arrived on Earth from outer space—specifically via a collision with a Mars-sized planet billions of ...

October is Breast Cancer Awareness Month and, according to the American Cancer Society, in this year alone more than 316,000 US women are projected to be diagnosed with an invasive ...

As an emerging 3D cell culture system, organoid technology has demonstrated substantial potential in basic research and ...